Transcriptional profiling in cancer: the path to clinical pharmacogenomics

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.2, Iss.2, 2001-05, pp. : 123-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Perspectives and challenges of clinical pharmacogenomics in cancer

By Pusztai Lajos

Pharmacogenomics, Vol. 5, Iss. 5, 2004-07 ,pp. : 451-454

Future Medicine

Access to resources Recommend Favorite

The blood option: transcriptional profiling in clinical trials

By Baird Alison E

Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. : 141-144

Future Medicine

Access to resources Recommend Favorite

Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies

By Burczynski Michael E Dorner Andrew J

Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. : 187-202

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

By Lentz Frederike Tran Agnès Rey Elisabeth Pons Gérard Tréluyer Jean-Marc

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 21-33

Adis International

Access to resources Recommend Favorite

Cancer Pharmacogenomics: DNA Genotyping and Gene Expression Profiling to Identify Molecular Determinants of Chemosensitivity

By Auman J. Todd McLeod Howard

Drug Metabolism Reviews, Vol. 40, Iss. 2, 2008-04 ,pp. : 303-315

Informa Healthcare

Access to resources Recommend Favorite